ckd and semaglutide Safety Efficacy of in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta‐Analysis - Abdullah - 2025 - Endocrinology, Diabetes & Metabolism Semaglutide Lowers Risk of Major
Description
The study sponsors were not involved in any stage of research design, execution, data analysis, manuscript preparation, or publication decisions
Also the oral absorption of GLP-1 receptor antagonists is extremely low
Semaglutide targets GLP-1R only
Telehealth platforms must have providers licensed in your state or work within interstate medical licensure compact agreements
Some research suggests tirzepatide may also influence energy balance and metabolic health, especially when combined with healthy lifestyle habits
